Efficacy of Topical Tofacitinib in Promoting Hair Growth in Non-Scarring Alopecia: Possible Mechanism via VEGF Induction

September 2017 in “ Archives of Dermatological Research ”

Jitlada Meephansan, J. Thummakriengkrai, Saranyoo Ponnikorn, Werayut Yingmema, Raksawan Deenonpoe, Poonkiat Suchonwanit

tofacitinib JAK3 inhibitor non-scarring alopecia minoxidil VEGF anagen phase hair follicles inflammation Rogaine

TLDR Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

In a study from September 7, 2017, researchers found that topical tofacitinib, a JAK3 inhibitor, was effective in promoting hair growth in non-scarring alopecia in male C57BL/6 mice. The study involved 28 mice divided into four groups, each treated with tofacitinib, minoxidil, or a control vehicle daily for 21 days. Tofacitinib-treated mice exhibited significantly more and faster hair regrowth compared to those treated with minoxidil or control, with regrowth starting as early as day 7. Histological analysis showed an increased number of hair follicles in the anagen phase and higher VEGF mRNA and protein expression levels in the tofacitinib group, suggesting a mechanism involving VEGF induction and reduced inflammation. The study concluded that tofacitinib could be a more effective treatment for hair growth than minoxidil, warranting further investigation into its long-term effects and safety.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

21 / 21 results

research Efficacy of Tofacitinib in Treatment of Alopecia Universalis in Two Patients

51 citations, June 2016 in “Journal of the European Academy of Dermatology and Venereology”

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

research Apoptosis in Follicles of Individuals with Female Pattern Hair Loss Is Associated with Perifollicular Microinflammation

30 citations, May 2016 in “International Journal of Cosmetic Science”

Hair loss in women links to inflammation around hair follicles.

research Treatment of an Alopecia Areata Patient with Tofacitinib Results in Regrowth of Hair and Changes in Serum and Skin Biomarkers

70 citations, April 2016 in “Experimental Dermatology”

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

research Topical Ruxolitinib for the Treatment of Alopecia Universalis

96 citations, December 2015 in “JAMA dermatology”

Topical Ruxolitinib may safely treat severe hair loss.

research Pharmacologic Inhibition of JAK-STAT Signaling Promotes Hair Growth

159 citations, October 2015 in “Science Advances”

Blocking JAK-STAT signaling can lead to hair growth.

research Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium Due to Topical Minoxidil Treatment

14 citations, January 2015 in “Skin appendage disorders”

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

research Platycarya Strobilacea S. Et Z. Extract Has a High Antioxidant Capacity and Exhibits Hair Growth-Promoting Effects in Male C57BL/6 Mice

12 citations, September 2014 in “Journal of Food Science and Nutrition”

Platycarya strobilacea extract is a strong antioxidant that can grow hair better than minoxidil.

research Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition

701 citations, August 2014 in “Nature medicine”

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

research Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

185 citations, June 2014 in “Journal of Investigative Dermatology”

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

research The Direct Inhibitory Effect of Dutasteride or Finasteride on Androgen Receptor Activity Is Cell Line Specific

12 citations, October 2013 in “The Prostate”

Dutasteride and finasteride affect different cell types differently.

research Paracrine TGF-β Signaling Counterbalances BMP-Mediated Repression in Hair Follicle Stem Cell Activation

321 citations, January 2012 in “Cell stem cell”

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

research Molecular Basis of Androgenetic Alopecia: From Androgen to Paracrine Mediators Through Dermal Papilla

122 citations, November 2010 in “Journal of Dermatological Science”

Male pattern baldness involves hormones and cell signals affecting hair growth.

research Molecular Dissection of Mesenchymal–Epithelial Interactions in the Hair Follicle

417 citations, September 2005 in “PLoS biology”

Understanding gene expression in hair follicles can reveal insights into hair growth and disorders.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

research Minoxidil: Mechanisms of Action on Hair Growth

397 citations, February 2004 in “British Journal of Dermatology”

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

research Hair Growth Effect of Minoxidil

25 citations, January 2002 in “Folia Pharmacologica Japonica”

Minoxidil helps hair grow by improving blood flow and increasing growth factors in hair follicles.

Minoxidil-Induced Hair Growth Is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil

research Minoxidil-Induced Hair Growth Is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil

83 citations, December 2001 in “Journal of Investigative Dermatology”

Minoxidil boosts hair growth by targeting adenosine and possibly sulfonylurea receptor 2B.

research Androgenetic Alopecia and Microinflammation

131 citations, August 2000 in “International Journal of Dermatology”

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

research Finasteride in the Treatment of Men with Androgenetic Alopecia

581 citations, October 1998 in “Journal of The American Academy of Dermatology”

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

research Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women

58 citations, October 1993 in “International Journal of Dermatology”

Minoxidil helps hair growth and reduces shedding in women.

research Topical Minoxidil in Male Pattern Baldness: Effects of Discontinuation of Treatment

57 citations, July 1987 in “Journal of The American Academy of Dermatology”

Stopping minoxidil treatment resumes balding; continuous use needed for results.

Related Research

8 / 8 results

Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?

research Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?

June 2022 in “Frontiers in Immunology”

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

research Clinical Response to Adjunctive Platelet-Rich Plasma Injections in a Patient with Alopecia Universalis on Oral Tofacitinib

1 citations, December 2021 in “JAAD case reports”

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Efficacy of Systemic Minoxidil and Tofacitinib Combination in Treatment-Resistant Alopecia Universalis

research An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

130 citations, February 2018 in “Journal of Investigative Dermatology”

Tofacitinib may help treat severe hair loss, but more research is needed.

research Efficacy of Topical Tofacitinib in Promoting Hair Growth in Non-Scarring Alopecia: Possible Mechanism via VEGF Induction

27 citations, September 2017 in “Archives of Dermatological Research”

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

research Hematological And Hepatic Effects Of Vascular Epidermal Growth Factor (VEGF) Used To Stimulate Hair Growth In An Animal Model

30 citations, October 2013 in “BMC dermatology”

VEGF gel increases hair growth but may have potential toxicity.